These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new research shows. Compared to another common ...

The researchers urged physicians to be vigilant for signs of pancreatitis and to monitor kidney function among people taking GLP-1 medications. Kidney problems can occur without symptoms until the ...

1 CKD progression risk was a significant 36% lower with GLP-1 RA vs DPP-4i ... world evidence in support of the renal-protective effect of GLP1-RA on kidney function in patients with moderate ...

Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what ...

as well as kidney issues. On the flip side, recent studies show that GLP-1 medications may decrease a person’s risk for cardiovascular disease and dementia. Now, a new study recently published ...

The increased risk of kidney stones, on the other hand, might be less familiar. “That may be related to the possibility that people, when they are on GLP-1, they definitely eat a whole lot less ...

GLP-1 agonists also were tied to 12% reduced risk for acute kidney injury and 3% lower risk ... and a stabilizing effect on endothelial function, which may be driving cardiovascular benefits ...